Our study supports the growing importance of identifying treatable traits in managing ILDs, as emphasized by Amati et al.31 Our findings align with existing studies suggesting severity of ILD, especially with associated advanced radiologic fibrotic features, are a negative predictor of treatment response with PMP.9 We found that a higher baseline CRP was associated with improvement, while traction bronchiectasis and the need for home oxygen were associated with poorer responses to PMP. The gene discussed is CRP; the disease is interstitial lung disease.